Novartis AG (NVS)
153.80
+2.68
(+1.78%)
USD |
NYSE |
Oct 26, 16:00
153.80
0.00 (0.00%)
After-Hours: 20:00
Novartis Price : 153.80 for Oct. 26, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 156.08 | 156.08 | 149.17 | 151.12 | 4.359M |
| Oct 22, 2026 | 154.90 | 157.10 | 154.38 | 156.27 | 2.081M |
| Oct 21, 2026 | 153.12 | 154.12 | 152.93 | 153.93 | 1.019M |
| Oct 20, 2026 | 152.15 | 153.68 | 151.95 | 153.64 | 1.357M |
| Oct 19, 2026 | 150.22 | 150.90 | 149.62 | 150.20 | 1.867M |
| Oct 16, 2026 | 150.65 | 151.74 | 150.23 | 150.62 | 1.729M |
| Oct 15, 2026 | 150.32 | 151.83 | 149.64 | 150.38 | 2.090M |
| Oct 14, 2026 | 144.35 | 147.16 | 144.17 | 146.88 | 1.647M |
| Oct 13, 2026 | 145.18 | 145.24 | 142.31 | 142.41 | 1.841M |
| Oct 12, 2026 | 143.84 | 144.02 | 143.12 | 143.84 | 1.150M |
| Oct 09, 2026 | 142.92 | 143.96 | 142.80 | 143.75 | 1.901M |
| Oct 08, 2026 | 142.77 | 143.29 | 140.68 | 143.11 | 1.533M |
| Oct 07, 2026 | 143.12 | 144.28 | 142.54 | 143.28 | 1.852M |
| Oct 06, 2026 | 141.32 | 141.39 | 139.66 | 140.79 | 1.574M |
| Oct 05, 2026 | 141.02 | 141.02 | 139.31 | 140.93 | 1.329M |
| Oct 02, 2026 | 141.46 | 141.57 | 139.95 | 141.00 | 2.247M |
| Oct 01, 2026 | 142.22 | 142.50 | 140.87 | 141.05 | 2.056M |
| Sep 30, 2026 | 145.39 | 145.50 | 142.56 | 142.57 | 3.062M |
| Sep 29, 2026 | 144.81 | 146.18 | 144.46 | 145.71 | 1.599M |
| Sep 28, 2026 | 145.77 | 147.03 | 145.72 | 146.88 | 1.949M |
| Sep 25, 2026 | 144.57 | 145.51 | 144.00 | 145.46 | 1.166M |
| Sep 24, 2026 | 143.00 | 144.66 | 142.91 | 143.57 | 1.888M |
| Sep 23, 2026 | 143.15 | 143.94 | 142.02 | 142.71 | 2.518M |
| Sep 22, 2026 | 141.26 | 141.80 | 140.00 | 141.28 | 1.544M |
| Sep 21, 2026 | 141.96 | 142.18 | 140.96 | 140.98 | 1.554M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Roche Holding AG | 61.17 |
| AstraZeneca PLC | 172.03 |
| GSK Plc | 51.11 |
| Johnson & Johnson | 266.50 |
| Eli Lilly & Co. | 1279.38 |
Price Related Metrics
| PE Ratio | 23.20 |
| PS Ratio | 5.403 |
| Price to Book Value | 6.777 |
| Price to Free Cash Flow | 19.75 |
| Earnings Yield | 4.31% |
| Market Cap | 281.55B |
| Operating PE Ratio | 18.26 |
| Normalized PE Ratio | 21.62 |